间歇性跛行患者肌肉形态与功能的系统综述
该系统综述检索MEDLINE、Cochrane Central和Embase(1947年至2016年6月,英文),纳入30篇文章、共2837例间歇性跛行患者,评估肌肉力量、大小、纤维类型和代谢四类指标。综述发现评估的肌群和力量测定方法繁多,无法明确究竟哪种「力量」指标受损,且潜在力量变化的形态学原因不清;数据异质性大,缺乏高质量干预性研究。
要点
- 间歇性跛行患者肌肉功能评估涉及力量、大小、纤维类型和代谢四类指标。
- 评估肌群和力量测定方法繁多,无法确定具体受损的力量指标。
- 数据异质性大,缺乏高质量干预性研究,需标准化测试和随机对照试验。
核心结论
- 综述发现评估的肌群和力量测定方法繁多,无法明确哪种「力量」指标受损。
- 潜在力量变化的形态学原因不清,数据异质性大且缺乏高质量干预研究。
研究设计与样本
- 系统综述纳入随机和非随机试验,检索MEDLINE、Cochrane Central和Embase数据库。
- 检索限1947年至2016年6月英文文献,最终纳入30篇文章,共2837例间歇性跛行患者。
主要发现
- 九项研究报告肌肉力量,包括等长、向心、离心和耐力测量。
- 八项研究报告肌肉大小,采用周长、CT和超声成像技术。
- 十一项研究报告肌肉纤维,包括纤维类型比例、纤维大小和毛细血管化测量。
- 七篇论文报告肌肉代谢,包括二磷酸腺苷恢复和磷酸肌酸恢复测量。
临床怎么用
- 临床需认识到间歇性跛行患者肌肉功能评估方法不统一,力量受损指标不明确。
- 设计运动干预前应参考标准化测试流程,未来需随机对照试验验证靶向治疗。
局限性
- 纳入研究异质性大,缺乏高质量干预性研究。
- 评估肌群和力量测定方法多样,无法确定具体受损的力量指标。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Intermittent claudication (IC) is frequently associated with deterioration in walking capacity and physical function, and it can often result in an impairment in balance. Whereas supervised exercise is recommended by the National Institute for Health and Care Excellence as the first-line treatment, the mechanism behind walking improvement is poorly understood. The existing literature suggests that there may be some physiologic change to the skeletal muscle contributing to the functional impairment, but these data are conflicting. We therefore sought to undertake a systematic review to clarify the muscle properties of patients with IC. METHODS: A systematic review of randomized and nonrandomized trials that investigated the role of muscle function in patients diagnosed with IC was undertaken using MEDLINE, Cochrane Central Register of Controlled Trials, and Embase databases. The searches were limited from 1947 to June 2016 in the English language. RESULTS: The search yielded a total of 506 articles, of which 206 were duplicate articles. Of the remaining 300, a total of 201 were excluded from full-text analysis; 99 full-text articles were assessed for eligibility, with 30 articles deemed appropriate for inclusion in the review. There were four main categories of functional outcome measures: muscle strength, muscle size, muscle fiber type, and muscle metabolism. A total of 2837 patients were included in the study. Nine studies reported on muscle strength, incorporating isometric, concentric, eccentric, and endurance measures. Eight studies reported on muscle size, incorporating circumference, computed tomography scans, and ultrasound imaging techniques. Eleven studies reported on muscle fibers, incorporating fiber type proportions, fiber size, and capillarity measures. Seven papers reported on muscle metabolism, incorporating adenosine diphosphate recovery and phosphocreatine recovery measures. CONCLUSIONS: Previous literature has found clear evidence that strength (of the calf and thigh musculature) and calf characteristics are related to mortality and functional declines. However, this review has demonstrated the vast array of muscle groups assessed and multiple methods employed to determine strength; therefore, it is unclear exactly what measure of "strength" is impaired. Furthermore, the underlying morphologic causes of potential changes in strength are unclear. This information is essential for designing optimal exercise interventions. The data acquired during this systematic review are heterogeneous, with a substantial lack of high-quality intervention-based studies. Future research should endeavor to establish standardized testing procedures and to implement randomized controlled trials for targeted therapeutic interventions.
引用
- Harwood AE, King S, Totty J, et al. A systematic review of muscle morphology and function in intermittent claudication. J Vasc Surg. 2017. PMID: 28822657. doi:10.1016/j.jvs.2017.05.106
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。